@font-face {
font-family: 黑体;
}
@font-face {
font-family: Cambria Math;
}
@font-face {
font-family: 仿宋_GB2312;
}
@font-face {
font-family: @黑体;
}
@font-face {
font-family: @仿宋_GB2312;
}
P.Msonormal {
FONT-SIZE: 16pt; FONT-FAMILY: "Times New Roman","serif"; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; TEXT-JUSTIFY: inter-ideograph; TEXT-INDENT: 10pt; mso-char-indent-count: 2.0; mso-style-unhide: no; mso-style-qformat: yes; mso-style-parent: ""; mso-pagination: none; mso-bidi-font-size: 11.0pt; mso-fareast-font-family: 仿宋_GB2312; mso-font-kerning: 1.0pt
}
LI.Msonormal {
FONT-SIZE: 16pt; FONT-FAMILY: "Times New Roman","serif"; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; TEXT-JUSTIFY: inter-ideograph; TEXT-INDENT: 10pt; mso-char-indent-count: 2.0; mso-style-unhide: no; mso-style-qformat: yes; mso-style-parent: ""; mso-pagination: none; mso-bidi-font-size: 11.0pt; mso-fareast-font-family: 仿宋_GB2312; mso-font-kerning: 1.0pt
}
DIV.Msonormal {
FONT-SIZE: 16pt; FONT-FAMILY: "Times New Roman","serif"; TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; TEXT-JUSTIFY: inter-ideograph; TEXT-INDENT: 10pt; mso-char-indent-count: 2.0; mso-style-unhide: no; mso-style-qformat: yes; mso-style-parent: ""; mso-pagination: none; mso-bidi-font-size: 11.0pt; mso-fareast-font-family: 仿宋_GB2312; mso-font-kerning: 1.0pt
}
.TRS_PreAppend .MsoChpDefault {
FONT-SIZE: 10pt; mso-hansi-font-family: "Times New Roman"; mso-bidi-font-size: 10.0pt; mso-fareast-font-family: 宋体; mso-font-kerning: 0pt; mso-style-type: export-only; mso-default-props: yes; mso-ansi-font-size: 10.0pt; mso-ascii-font-family: "Times New Roman"
}
UNKNOWN {
mso-page-border-surround-header: no; mso-page-border-surround-footer: no
}
UNKNOWN {
MARGIN: 72pt 90pt; size: 612.0pt 792.0pt; mso-header-margin: 36.0pt; mso-footer-margin: 36.0pt; mso-paper-source: 0
}
DIV.WordSection1 {
page: WordSection1
}
北京信得威特科技有限公司畜类及特种动物疫苗高技术产业化示范工程项目，由国家发展改革委批准列入国家高技术产业发展项目计划及国家资金补助计划（发改办高技[2011]1158号），现申请项目验收。
该企业在验收报告中申明：该项目建设了总建筑面积5760平方米的动物疫苗车间，其中建成1条胚苗生产线、2条细胞苗生产线和1条成品生产线，实现了狂犬病灭活疫苗年产1000万头份、猪蓝耳病灭活疫苗年产5000万毫升、禽流感灭活疫苗年产27500万毫升、新城疫-禽流感二联灭活疫苗年产15000万毫升的产能。该项目生产的狂犬病灭活疫苗为国家二类新兽药，填补了国内空白。
有关单位和个人对该企业及项目如有意见，请在本公告发布日起10日内书面告知我委（书面意见中请注明“高技术项目意见”）。
联系方式：66415588-0521；传真：66410835
电子邮件：bjwgjc@beic.gov.cn
2013年12月9日
收藏本文
